Viren Mahurkar is Founder and Chairman of HitchinRock Advisors, a boutique consulting firm for financial investors and mid-sized companies that need specialized expertise in M&A, licensing or investments in biomedical assets and technologies. He brings global experience and divides his time between London, New York, Singapore.
Over the last 30+ years, Viren has held global and regional leadership roles at pharmaceutical and medtech companies including Pfizer, Novartis, Alcon and Wockhardt. He has led projects and deals involving US, European and Asian pharma, biotechs and medtechs, across the range from new technologies and unmet medical needs to ongoing commercial operations. He enjoys collaborating closely with R&D, clinical, regulatory, manufacturing, IP, legal, product launch, market access, sales & marketing colleagues.
Viren also has years of senior banking experience with Citibank, Standard Chartered, Ambit Capital and ICICI Securities. He has worked across trade finance, FX advisory, merchant banking and securities services and retains close ties to US, Europe and Asia investor ecosystems. These experiences help him add value to investment conversations through nurturing new ideas and themes and through convictions facilitated by biomedical insights and ease of corporate access. He is adept at customizing ideas within context of global macro, asset class and sector rotation, investor portfolio dynamics and liquidity / exit opportunities.
Viren is deeply interested in the intersection of biomedical innovation and its financing. He is a speaker and active participant on these and related topics at pharma, biotech, medtech, BD&L and investor forums. His qualifications include an MBA (University of Delhi); MSc (London School of Economics); an executive leadership programme (Harvard Business School); Alternative investment (CAIA); Quant Finance (CQF) and advanced courses in biotech and healthcare.